Estimates of Impairment Losses and Deferred Tax Assets Based on a Prolonged COVID-19 Pandemic
First written in FY2021-Q2. 6 of 10 entries say "Restated". Latest entry: FY2023-Q3.
Washington Hotel moved to the "Worse" side of this theme in 2021, 2 years before the typical company in this theme (2023).
The whole theme swung hardest in 2026: 3 of 9 companies on the "Worse" side.
43 other companies' latest entry also says "Restated".
- FY2023-Q3RestatedAnnual report
「There were no significant changes to the assumptions concerning the effects of the spread of COVID-19 described under “Significant Accounting Estimates” in the securities report for the previous fiscal year.」
The company restated that there had been no significant changes to the accounting assumption that the effects of COVID-19 would continue. - FY2023-Q2RestatedAnnual report
「There were no significant changes to the assumptions concerning the effects of the spread of COVID-19 described under “Significant Accounting Estimates” in the securities report for the previous fiscal year.」
The company restated that there had been no significant changes from the previous fiscal year in the accounting estimates based on the assumption that the infectious disease would continue for an extended period. - FY2023-Q1RestatedAnnual report
「There were no significant changes to the assumptions concerning the effects of the spread of COVID-19 described under “Significant Accounting Estimates” in the securities report for the previous fiscal year.」
The company restated that there had been no significant changes to the accounting assumption that the effects of COVID-19 would continue. - FY2022MaterialisedAnnual report
「In addition, ¥157.682 million in applications for employment adjustment subsidies and other assistance related to COVID-19 was recorded as employment adjustment subsidies, while ¥211.955 million in cooperation payments and other assistance for shortening business hours by restaurants was recorded as receipts of cooperation payments to prevent the spread of infection, both as non-operating income. An impairment loss of ¥68.363 million on the company's fixed assets and ¥53.503 million in losses from closing business locations were recorded as extraordinary losses.」
An impairment loss of ¥68.363 million on fixed assets was recorded in connection with the effects of the infectious disease and declining profitability. - FY2022-Q3RestatedAnnual report
「There have been no material changes to the assumptions concerning the impact of the spread of COVID-19 described in the previous fiscal year's securities report under Additional Information.」
The company restated that there had been no significant changes in the accounting assumption that the effects of COVID-19 would continue for a certain period. It recorded an impairment loss of ¥25.975 million in the cumulative third-quarter period. - FY2022-Q2RestatedAnnual report
「There have been no material changes to the assumptions concerning the impact of the spread of COVID-19 described in the previous fiscal year's securities report under Additional Information.」
The company restated that there had been no significant changes in the accounting assumption that the effects of the infectious disease would continue for a certain period. It also recorded an impairment loss of ¥25.743 million in the cumulative second-quarter period. - FY2022-Q1WorsenedAnnual report
「Due to declining profitability and other factors, the carrying amount of the above asset group has been reduced to its recoverable amount.」
Although there were no significant changes in the accounting assumptions concerning the effects of the infectious disease, an impairment loss of ¥20.470 million was recorded in the first quarter due to declining profitability. - FY2021WorsenedAnnual report
「Assuming that the impact of COVID-19 on the business would continue for a certain period beyond the fiscal year ending March 2022, we made accounting estimates concerning impairment of fixed assets and the recoverability of deferred tax assets. As a result, we recognized impairment losses on fixed assets and wrote down deferred tax assets.」
Based on accounting estimates made on the assumption that the effects of the infectious disease would continue, the company recorded an impairment loss of ¥93.609 million for the full year and reversed its deferred tax assets. - FY2021-Q3RestatedAnnual report
「After comprehensively considering the reissuance of a declaration of a state of emergency and currently available external information, among other factors, we made accounting estimates concerning impairment of fixed assets and the recoverability of deferred tax assets, assuming that the impact of COVID-19 would continue for a certain period beyond the fiscal year ending March 2022 and that we would pursue further cost reductions.」
The company continued to estimate impairment losses and deferred tax assets based on the assumption that the impact of the infection would continue beyond the fiscal year ending March 2022 and on the premise of cost reductions. - FY2021-Q2First statedAnnual report
「While assuming that the impact of COVID-19 on sales would continue for a certain period beyond the fiscal year ending March 2022, we made accounting estimates concerning impairment of fixed assets and the recoverability of deferred tax assets on the assumption that we would pursue further cost reductions. As a result, we recognized impairment losses on fixed assets and wrote down deferred tax assets.」
Assuming that the impact of the infection on sales would continue beyond the fiscal year ending March 2022, the company recognized an impairment loss on fixed assets of ¥39.333 million and wrote down deferred tax assets.